Curaleaf Holdings (CURLF) Cash from Financing Activities (2019 - 2024)

Curaleaf Holdings (CURLF) recorded quarterly Cash from Financing Activities of -$6.6 million in Q4 2024, up 46.11% quarter-over-quarter from -$12.2 million in Q3 2024, and up 61.27% on a YoY basis from -$4.1 million in Q1 2024.

Curaleaf Holdings (CURLF) Cash from Financing Activities (2019 - 2024) Analysis & Trends

Curaleaf Holdings' Cash from Financing Activities history runs 6 years deep, the most recent figure standing at -$6.6 million for Q4 2024.

  • In Q4 2024, Cash from Financing Activities rose 61.27% year-over-year to -$6.6 million; the TTM figure through Dec 2024 stood at -$54.1 million (up 19.26% YoY), while the FY2025 annual figure was -$73.5 million, down 35.86% from the prior year.
  • Cash from Financing Activities was -$6.6 million for Q4 2024 at Curaleaf Holdings, up from -$12.2 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $28.6 billion in Q2 2023 to a low of -$28.6 billion in Q1 2023.
  • Historically, Cash from Financing Activities has averaged $27.4 million across 5 years, with a median of $1.7 million in 2020.
  • Biggest YoY gain for Cash from Financing Activities was 59634.52% in 2023; the steepest drop was 171254.23% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $3.4 million in 2020, then jumped by 2674.62% to $95.2 million in 2021, then sank by 59.52% to $38.6 million in 2022, then tumbled by 144.07% to -$17.0 million in 2023, then soared by 61.27% to -$6.6 million in 2024.
  • The last three Cash from Financing Activities figures came in at -$6.6 million (Q4 2024), -$12.2 million (Q3 2024), and -$15.7 billion (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 13.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 1.47 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -11.62 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -77.88 Mn
10 Curaleaf Holdings - - 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -6.58 Mn
Dec 31, 2024 -6.58 Mn
Sep 30, 2024 -12.21 Mn
Sep 30, 2024 -12.21 Mn
Jun 30, 2024 -15.73 Bn
Jun 30, 2024 -15.73 Bn
Mar 31, 2024 15.70 Bn
Mar 31, 2024 15.70 Bn
Dec 31, 2023 -16.99 Mn
Dec 31, 2023 -16.99 Mn
Sep 30, 2023 5.06 Mn
Sep 30, 2023 5.06 Mn
Jun 30, 2023 28.59 Bn
Jun 30, 2023 28.59 Bn
Mar 31, 2023 -28.65 Bn
Mar 31, 2023 -28.65 Bn
Dec 31, 2022 38.55 Mn
Dec 31, 2022 38.55 Mn
Sep 30, 2022 -27.89 Mn
Sep 30, 2022 -27.89 Mn